ChemoSen3D grew out of Nano3D Biosciences (n3D) which was a State of Texas C-Corporation founded in 2008 by Glauco R. Souza, Thomas Killian, David Lee, and Robert Raphael. n3D commercialized products and services utilizing the Bio-Assembler™ technology created by Glauco R. Souza (U.T. MD Anderson Cancer Center), Thomas Killian (Rice University) and Robert Raphael (Rice University). The n3D business strategy has been created by all team members under the business leadership of David Lee. n3D was a Houston Technology Center client company, and it had been recognized with a Rice Alliance “Most Promising Life Science Company” award (2009), received approximately $2,000,000 in non-diluting funds from grants, a Pre-Seed Commercialization Award of $1,000,000 from the Texas Emerging Technology Fund (2010), and a $10,000 Goradia Innovation Prize (2010). N3D’s magnetic 3D culturing technology was sold to Greiner-Bio One in 2018 and now ChemoSen3D is moving forward into the clinical diagnostic space.